| abstract |
A pharmaceutical composition for heart disease having as an active ingredient a pathologically effective amount of a benzopyran derivative expressed by the following general formula (I): wherein R1 is an alkyl group having 1-10 carbon atoms or an alkenyl group having 2-10 carbon atoms, and R2 is an alkyl group having 2-4 carbon atoms and one hydroxyl group, an alkyl group having 3-4 carbon atoms and two hydroxyl groups, a benzoyl group, a glucosyl group, a mannosyl group, a galactosyl group or a dimethyl-dioxolanyl-4-ethyl group; or physiologically acceptable salts thereof. |